If you choose to customise the site it will help you to find the most relevant content for your needs. You will still be able to access all content on the site.
Don't have an account?
Click here to register
The patient's choice makes it difficult to monitor their condition and is a particular concern if they are taking high-risk drugs...
The MDU has noticed an increase in notification of claims related to renal impairment alleged to be secondary to mesalazine prescribed for inflammatory bowel disease.
Patients travelling to malaria hotspots should be encouraged to seek early medical advice about preventative measures.
Effective systems for tracking test results will minimise risk of delayed diagnosis.